How to Help Your Patients Find Estratest In Stock: A Provider's Guide

If you prescribe Estratest (esterified estrogens/methyltestosterone), you've likely received calls or messages from patients who cannot fill their prescription. These calls are time-consuming for your practice — and stressful for your patients. Having a clear, reproducible workflow to address them can save your staff hours per week and ensure patients get continuity of care.

This guide provides a practical playbook for your practice: how to help patients find EEMT quickly, when to pivot to alternatives, and how to streamline the process.

Why Patients Call About Estratest Availability

Estratest and its generic equivalents (EEMT, Covaryx) are produced by only a handful of manufacturers, contain a DEA-regulated ingredient (methyltestosterone), and serve a niche patient population. These factors combine to create persistent, intermittent stock gaps at retail pharmacies. Patients may be unable to fill their prescription at their usual pharmacy even when it isn't formally in a national shortage.

The situation is compounded by the fact that pharmacies list this medication under several different names — Estratest, EEMT, Covaryx, esterified estrogens/methyltestosterone — and pharmacists unfamiliar with the full list of generics may tell patients it's unavailable when another form is in stock.

Step 1: Give Patients a Pharmacy Search Script at Prescribing Time

When prescribing EEMT, proactively equip patients with what they need to find it. Consider a brief written or verbal instruction at the appointment:

Tell them to ask for the medication by all generic names: EEMT, EEMT HS, Covaryx, Covaryx HS, esterified estrogens/methyltestosterone

Tell them to specify the exact strength (full strength 1.25 mg/2.5 mg or half strength 0.625 mg/1.25 mg)

Advise them to start calling around 1–2 weeks before running out, not the day of

Mention that independent pharmacies often have better luck than major chains for this medication

Step 2: Direct Patients to medfinder for Pharmacy Searches

medfinder is a service that calls pharmacies near a patient to check which ones have their specific medication and dose in stock. It reduces the patient's burden from calling 5–10 pharmacies themselves, and it reduces your staff's burden from fielding those frustrated follow-up calls. Consider adding medfinder.com to your patient instruction handouts or after-visit summary for all EEMT prescriptions. Learn more at medfinder.com/providers.

Step 3: Build Relationships with Local Pharmacies That Stock It

If your practice sees a significant volume of EEMT patients, it's worth identifying one or two local independent pharmacies or specialty compounding pharmacies that reliably source this medication. Maintain that relationship — and share it with patients when they call with availability issues.

Some OB/GYN and menopause specialty practices maintain a short list of "go-to pharmacies" for hard-to-find medications. Even a list of 2–3 reliable options for your catchment area can dramatically reduce the amount of time staff spend on medication access calls.

Step 4: Consider Mail-Order Pharmacy for Long-Term Patients

For patients who are stable on EEMT and expect to continue long-term, mail-order pharmacy through their insurance plan can provide more reliable supply than retail pharmacies. Specialty mail-order pharmacies like Express Scripts, OptumRx, and CVS Caremark often maintain larger centralized inventories.

Key note: Because EEMT contains methyltestosterone, controlled substance dispensing rules may apply in some states. Mail-order may be limited to 30-day supplies and may require e-prescribing with EPCS (Electronic Prescribing for Controlled Substances) depending on the formulation and state. Verify with the patient's insurance mail-order pharmacy before directing them there.

Step 5: Have a Compounding Prescription Ready as a Backup

If commercial EEMT is unavailable in your patient's area and the supply situation is expected to persist, a compounding pharmacy can prepare the same formulation. Having a compounding prescription template ready — and a vetted compounding pharmacy to refer patients to — eliminates delays when this situation arises.

Remember to document the clinical rationale for compounding and discuss the differences with the patient (no FDA oversight of compounded drugs, potential for potency variability, insurance typically won't cover compounded medications).

When to Pivot to an Alternative: Clinical Decision Points

Not every patient needs to remain on EEMT indefinitely. Consider a therapeutic substitution when:

Supply has been unavailable for 2+ weeks and symptoms are returning

The patient is experiencing significant androgenic side effects (hirsutism, voice changes, acne) that prompt a reevaluation of whether the testosterone component is still needed

The patient's insurance no longer covers EEMT and cost is a barrier

The patient has been on therapy long enough to warrant a reassessment of whether the androgen component is still clinically necessary

Appropriate alternatives include estradiol monotherapy (add progestogen if uterus intact), Prempro, Bijuva, or Activella, depending on the patient's symptom profile, uterine status, and preference.

Staff Workflow: Handling the "I Can't Fill My Estratest" Call

Train your front desk or triage staff to follow this sequence when a patient calls about EEMT availability:

Ask which pharmacy they tried and what exact name they used (they may have only asked for "Estratest")

Give the patient the list of all generic names to use when calling other pharmacies

Direct them to medfinder.com for a phone-call-free pharmacy search

Mention your go-to local independent pharmacy if you have one

If the patient has been unable to fill for more than 7–10 days, escalate to the prescriber for consideration of compounding or therapeutic substitution

Summary

EEMT availability challenges are likely to continue through 2026. Proactive provider workflows — educating patients at prescribing time, directing them to tools like medfinder, maintaining pharmacy relationships, and having a clear threshold for therapeutic substitution — reduce the burden on your staff and ensure your patients aren't left without treatment.